| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/03/2011 | WO2011023389A1 Humanized anti-cdcp1 antibodies |
| 03/03/2011 | WO2011023130A1 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody |
| 03/03/2011 | WO2011006915A3 Improved anti-serum albumin binding single variable domains |
| 03/03/2011 | WO2010148223A3 Anti-vegf antibodies and their uses |
| 03/03/2011 | WO2010141902A3 METHODS FOR IDENTIFICATION OF SITES FOR IgG CONJUGATION |
| 03/03/2011 | WO2010129033A3 Modified antibodies for passive immunotherapy |
| 03/03/2011 | WO2010127252A3 Monoclonal antibodies to influenza h1n1 virus and uses thereof |
| 03/03/2011 | WO2010124163A3 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies |
| 03/03/2011 | WO2010121093A3 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/03/2011 | WO2010120501A3 Assys for bacterial detection and identification |
| 03/03/2011 | WO2010104748A3 Antigen presenting cell targeted anti-viral vaccines |
| 03/03/2011 | WO2010039900A3 Non-human mammals for the production of chimeric antibodies |
| 03/03/2011 | WO2008152447A3 Staphylococcus aureus specific anti-infectives |
| 03/03/2011 | US20110055943 Novel therapeutic targets in inflammatory bowel disease |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110055938 Transgenic animal for production of antibodies having minimal cdrs |
| 03/03/2011 | US20110054158 Polynucleotides encoding class ii cytokine receptor-7 |
| 03/03/2011 | US20110054151 Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| 03/03/2011 | US20110054150 Methods of Treating Inflammatory Pain |
| 03/03/2011 | US20110054149 NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases |
| 03/03/2011 | US20110054148 Antibodies to interferon-like protein zcyto21(il-29) |
| 03/03/2011 | US20110053850 Doc1 compositions and methods for treating cancer |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 03/03/2011 | US20110053787 Compositions and Methods of Detecting Post-Stop Peptides |
| 03/03/2011 | US20110053781 Methods and compositions for polypeptide engineering |
| 03/03/2011 | US20110053292 signal amplification technique for mass analysis |
| 03/03/2011 | US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator |
| 03/03/2011 | US20110053254 Materials and methods relating to modifying the binding of antibodies |
| 03/03/2011 | US20110053243 Asymmetrically branched polymer conjugates and microarray assays |
| 03/03/2011 | US20110053242 Immunoaffinity isolation of modified peptides from complex mixtures |
| 03/03/2011 | US20110053221 Recombinant production of authentic human proteins using human cell expression systems |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053214 Production of galactosylated glycoproteins in lower eukaryotes |
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/03/2011 | US20110053175 Asymmetrically branched polymer conjugates and microarray assays |
| 03/03/2011 | US20110053142 Binding Protein and Epitope-Blocking Elisa for the Universal Detection of H5-Subtype Influenza Viruses |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052642 Peripheral zone tumor cells, methods for their preparation and use |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052610 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 03/03/2011 | US20110052608 Novel antibodies against prion protein and uses thereof |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052604 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052595 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/03/2011 | US20110052593 Breast cancer associated antigen |
| 03/03/2011 | US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin |
| 03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052588 Method of treating hepatocellular carcinoma |
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
| 03/03/2011 | US20110052586 Antibodies to an epitope of agr2, assays and hybridomas |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
| 03/03/2011 | US20110052582 Humanized Anti-CDCP1 Antibodies |
| 03/03/2011 | US20110052577 Antibodies |
| 03/03/2011 | US20110052575 Anti-vegf antibodies |
| 03/03/2011 | US20110052574 Method of inhibition of leukemic stem cells |
| 03/03/2011 | US20110052573 14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | US20110052570 Method to prognose response to anti-egfr therapeutics |
| 03/03/2011 | US20110052565 Non-aggregating human vh domains |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | US20110052499 Baboon homolog of human cd147 |
| 03/03/2011 | US20110052498 Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders |
| 03/03/2011 | CA2772572A1 Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof |
| 03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/03/2011 | CA2772380A1 Methods of treatment using anti-oxidized ldl antibodies |
| 03/03/2011 | CA2772298A1 Methods for creating antibody libraries |
| 03/03/2011 | CA2772224A1 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
| 03/03/2011 | CA2772204A1 Methods and compositions for the inhibition of transplant rejection |
| 03/03/2011 | CA2772199A1 B7-h4 fusion proteins and methods of use thereof |
| 03/03/2011 | CA2771781A1 Antikine antibodies that bind to multiple cc chemokines |
| 03/03/2011 | CA2771575A1 Therapeutic dll4 binding proteins |
| 03/03/2011 | CA2771186A1 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 03/03/2011 | CA2770351A1 Compositions and methods of use of immunotoxins comprising ranpirnase (rap) show potent cytotoxic activity |
| 03/03/2011 | CA2770174A1 Affinity-matured humanized anti cea monoclonal antibodies |
| 03/03/2011 | CA2770173A1 Velocity factor |
| 03/03/2011 | CA2770161A1 Humanized anti-cdcp1 antibodies |
| 03/03/2011 | CA2770141A1 Antibodies against cdcp1 for the treatment of cancer |
| 03/03/2011 | CA2754024A1 Antibody fusion-mediated plant resistance against oomycota |
| 03/02/2011 | EP2290361A1 Methods for selecting a colorectal carcinoma treatment |
| 03/02/2011 | EP2290104A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 03/02/2011 | EP2290103A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 03/02/2011 | EP2290088A1 Methods for producing soluble multi-menbrane-spanning proteins |
| 03/02/2011 | EP2290087A2 Methods for producing soluble multi-membrane-spanning proteins |
| 03/02/2011 | EP2290086A2 Methods for producing soluble multi-membrane-spanning proteins |
| 03/02/2011 | EP2290082A1 Streptococcus pyogenes antigens |
| 03/02/2011 | EP2290081A2 IL-17 homologous polypeptide and therapeutic uses thereof |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2290077A2 Natural IGM antibodies and inhibitors thereof |
| 03/02/2011 | EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications |
| 03/02/2011 | EP2289944A2 Bispecific antibody substituting for functional proteins |
| 03/02/2011 | EP2289943A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
| 03/02/2011 | EP2289942A2 Anti-HER2 antibody variants |
| 03/02/2011 | EP2289941A2 Administration of agents for the treatment of inflammation |
| 03/02/2011 | EP2289940A2 Treatment of metastatic disease |
| 03/02/2011 | EP2289939A2 PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy |